All News

Autologous

Mind the Gap: Transforming Cell & Gene Therapies from Scientific Success to Available Cures
29 August 2022
Mind the Gap: Transforming Cell & Gene Therapies from Scientific Success to Available Cures
Ohad Karnieli, Founder and CEO
New Technologies for Cell Therapy Manufacturing with Invetech
26 August 2022
New Technologies for Cell Therapy Manufacturing with Invetech
David Hodl, Head of Business
Pain Points to Optimising Automated Manufacturing Transitions
7 February 2022
Pain Points to Optimising Automated Manufacturing Transitions
Event Report
Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow
19 January 2022
Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow
Interview - Q&A
POPULAR NEWS ITEMS
Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

Image
22 September 2022

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image
22 September 2022

Looking to the Future of CAR-T Cell Therapy Manufacture

Scalability & Decentralised Manufacture Vs Comparability and Potency Assays: Pain Points and Opportunities
19 October 2021
Scalability & Decentralised Manufacture Vs Comparability and Potency Assays: Pain Points and Opportunities
Event Report
Automating Release for Autologous Products
8 August 2021
Automating Release for Autologous Products
Point of Care CAR-T with Adva Biotechnologies
1 July 2021
Point of Care CAR-T with Adva Biotechnologies
Watch as Ohad introduces the
Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
3 March 2021
Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
Are induced pluripotent stem cells
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

CAR-T Manufacturing Challenges and How to Overcome Them

Image

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image

Looking to the Future of CAR-T Cell Therapy Manufacture